Skip to main content
logo
Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
19.31
-1.86 (-8.79%)
At close: Oct 6, 2026, 4:00 PM EDT
19.13
-0.18 (-0.93%)
Pre-market: Oct 7, 2026, 8:15 AM EDT

Immunome Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-254.32-212.39-292.96-106.81-36.9-24.71
Depreciation & Amortization
3.422.962.10.730.630.76
Loss (Gain) From Sale of Assets
0.080.9----
Asset Writedown & Restructuring Costs
1010152.3480.8--
Loss (Gain) From Sale of Investments
-1.26-2.84-2.9-0.51--
Stock-Based Compensation
31.3925.6915.756.225.333.45
Other Operating Activities
------0.5
Change in Accounts Payable
2.2-9.169.53-0.61-0.681.78
Change in Unearned Revenue
--6.94-9.0415.98--
Change in Other Net Operating Assets
-0.310.8814.39-3.382.921
Operating Cash Flow
-208.79-190.92-110.79-7.57-28.69-18.23
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-10.29-9.69-7.17-0.83-0.25-0.08
Cash Acquisitions
---9.28--
Sale (Purchase) of Intangibles
-9.01-6.25-46.34---
Investment in Securities
-177.1876.73-31.56-38.93--
Investing Cash Flow
-196.4860.8-85.06-30.48-0.25-0.08

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
------0.11
Net Debt Issued (Repaid)
------0.11
Issuance of Common Stock
508.17679.81255.760.410.0328.66
Other Financing Activities
-29.07-39.46-15.23116--0.78
Financing Cash Flow
479.11640.36240.53116.410.0327.77

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
73.83510.2444.6778.36-28.919.46

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-219.09-200.6-117.97-8.4-28.94-18.31
Free Cash Flow Growth
------
Free Cash Flow Margin
--2890.13%-1304.80%-59.92%--
Free Cash Flow Per Share
-2.14-2.30-2.01-0.42-2.39-1.59
Levered Free Cash Flow
-143.66-133.62-96.32-1.65-14.89-8.75
Unlevered Free Cash Flow
-143.66-133.62-96.32-1.65-14.89-8.74

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0.01
Change in Working Capital
1.89-15.2314.87122.242.78
SEC Filings: 10-K · 10-Q